Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-31 07:46 am Unchanged | 13G | Xilio Therapeutics Inc. XLO | TAKEDA PHARMACEUTICAL CO LTD TAK | 1,475,121 4.000% | 0 (Unchanged) | View |
| 2024-04-10 06:10 am Sale | 13D | Phathom Pharmaceuticals Inc. PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 2,790,480 4.800% | -362,737 (-11.50%) | View |
| 2024-04-01 06:15 am Sale | 13D | Phathom Pharmaceuticals Inc. PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 3,153,217 5.400% | -602,366 (-16.04%) | View |
| 2024-02-06 09:36 am Purchase | 13G | TAKEDA PHARMACEUTICAL CO LTD S TAK | BlackRock Inc. BLK | 121,185,145 7.700% | 7,435,760 (+6.54%) | View |
| 2024-02-05 06:24 am Sale | 13G | TAKEDA PHARMACEUTICAL CO LTD S TAK | Sumitomo Mitsui Trust Group Inc. | 87,400,834 5.500% | -6,198,700 (-6.62%) | View |
| 2024-01-25 06:11 am Sale | 13D | Phathom Pharmaceuticals Inc. PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 3,755,583 6.600% | -3,703,721 (-49.65%) | View |
| 2024-01-19 06:03 am Purchase | 13G | Equillium Inc. EQ | TAKEDA PHARMACEUTICAL CO LTD TAK | 1,842,977 5.200% | 1,842,977 (New Position) | View |
| 2023-05-26 07:08 am Sale | 13D | CALITHERA BIOSCIENCES INC CALA | TAKEDA PHARMACEUTICAL CO LTD TAK | 0 0.000% | -857,844 (Position Closed) | View |
| 2023-02-07 2:10 pm Purchase | 13G | TAKEDA PHARMACEUTICAL CO LTD S TAK | BlackRock Inc. BLK | 113,749,385 7.200% | 8,807,433 (+8.39%) | View |
| 2023-02-03 5:06 pm Unchanged | 13G | Day One Biopharmaceuticals Inc. DAWN | TAKEDA PHARMACEUTICAL CO LTD TAK | 0 0.000% | 0 (Unchanged) | View |
| 2023-02-03 11:50 am Sale | 13G | Ovid Therapeutics Inc. OVID | TAKEDA PHARMACEUTICAL CO LTD TAK | 0 0.000% | -6,012,758 (Position Closed) | View |
| 2023-02-03 11:48 am Purchase | 13G | Ovid Therapeutics Inc. OVID | TAKEDA PHARMACEUTICAL CO LTD TAK | 8,781,996 12.200% | 1,250,000 (+16.60%) | View |
| 2023-02-03 06:19 am Purchase | 13G | TAKEDA PHARMACEUTICAL CO LTD S TAK | Sumitomo Mitsui Trust Group Inc. | 93,599,534 5.900% | 2,685,800 (+2.95%) | View |
| 2022-08-04 7:59 pm Unchanged | 13G | BIOMX INC PHGE | TAKEDA PHARMACEUTICAL CO LTD TAK | 1,478,286 4.960% | 0 (Unchanged) | View |
| 2022-07-06 06:12 am Sale | 13D | CALITHERA BIOSCIENCES INC CALA | TAKEDA PHARMACEUTICAL CO LTD TAK | 857,844 15.000% | -13,959,640 (-94.21%) | View |
| 2022-05-09 06:08 am Purchase | 13D | HILLEVAX INC HLVX | TAKEDA PHARMACEUTICAL CO LTD TAK | 6,724,000 17.100% | 6,724,000 (New Position) | View |
| 2022-04-21 06:06 am Purchase | 13D | CALITHERA BIOSCIENCES INC CALA | TAKEDA PHARMACEUTICAL CO LTD TAK | 14,817,484 13.200% | 14,817,484 (New Position) | View |
| 2022-02-04 06:09 am Sale | 13G | TAKEDA PHARMACEUTICAL CO LTD S TAK | Sumitomo Mitsui Trust Group Inc. | 90,913,734 5.700% | -3,120,300 (-3.32%) | View |
| 2022-02-02 7:18 pm Purchase | 13G | TAKEDA PHARMACEUTICAL CO LTD S TAK | BlackRock Inc. BLK | 104,941,952 6.600% | 5,393,016 (+5.42%) | View |
| 2022-01-14 06:07 am Purchase | 13G | Xilio Therapeutics Inc. XLO | TAKEDA PHARMACEUTICAL CO LTD TAK | 1,475,121 5.370% | 1,475,121 (New Position) | View |